Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Jonatan Salzer

Jonatan Salzer

Jag är överläkare och docent i neurologi. Mina forskningsprojekt handlar om yrsel, stroke och MS

Kontakt

E-post
jonatan.salzer@umu.se
Telefon

Verksam vid

Anknytning
Anknuten som läkare till Institutionen för klinisk vetenskap Enhet: Neurovetenskaper
Plats
Norrlands universitetssjukhus, Umeå universitet, Klinisk vetenskap Umeå universitet, Klinisk vetenskap, 901 85 Umeå

Jag arbetar som överläkare i neurologi vid Neuro-Huvud-Hals-Centrum, i första hand inom akutneurologi, stroke och neuroimmunologi. Min forskning är inriktad på rehabilitering efter akut yrsel, strokediagnostik och behandling vid akut yrsel Projekt Obalans, rituximabbehandling vid multipel skleros samt prevention av post-lumbalpunktionshuvudvärk. Jag sitter som norra sjukvårdsregionens representant i Nationella programområdet för nervsystemets sjukdomar inom kunskapsstyrningsorganisationen.

Jag jobbar bl.a. tillsammans med Anna Diamant (doktorand), Gabriel Granåsen (statistiker), Helena Grip (ingenjör), Fredrik Öhberg (ingenjör), Sun Sun (hälsoekonom), Solmaz Surano (postdoc), Erik Faergeman (doktorand) och Mariann Haapalahti (forskningssköterska).

Comparison Between the Video Head Impulse Test and Caloric Irrigation During Acute Vertigo
Indian Journal of Otolaryngology and Head and Neck Surgery
Olivecrona, Elin; Zborayova, Katarina; Barrenäs, Marie-Louise; et al.
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
Lancet Neurology, Elsevier 2022, Vol. 21, (8) : 693-703
Svenningsson, Anders; Frisell, Thomas; Burman, Joachim; et al.
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis
Journal of Neurology, Springer 2021, Vol. 268, (6) : 2161-2168
Boremalm, Malin; Sundström, Peter; Salzer, Jonatan
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations
Multiple Sclerosis Journal, Sage Publications 2021, Vol. 27, (12) : 1814-1822
Ghezzi, Angelo; Banwell, Brenda; Bar-Or, Amit; et al.
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis: a presymptomatic case–control study
European Journal of Neurology, John Wiley & Sons 2021, Vol. 28, (9) : 3072-3079
Grut, Viktor; Biström, Martin; Salzer, Jonatan; et al.
Variability of Normal Pressure Hydrocephalus Imaging Biomarkers with Respect to Section Plane Angulation: How Wrong a Radiologist Can Be?
American Journal of Neuroradiology, American Society of Neuroradiology 2021, Vol. 42, (7) : 1201-1207
Ryska, P.; Slezak, O.; Eklund, A.; et al.
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Annals of Neurology, John Wiley & Sons 2020, Vol. 87, (5) : 688-699
Alping, Peter; Askling, Johan; Burman, Joachim; et al.
Normative video head impulse test data in subjects with and without vascular risk factors
European Archives of Oto-Rhino-Laryngology, Springer Berlin/Heidelberg 2020, Vol. 278, (7) : 2619-2624
Hansson, Anders; Salzer, Jonatan
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurology, American Medial Association 2020, Vol. 177, (2) : 184-191
Luna, Gustavo; Alping, Peter; Burman, Joachim; et al.
Radiological markers of idiopathic normal pressure hydrocephalus: Relative comparison of their diagnostic performance
Journal of the Neurological Sciences, Elsevier 2020, Vol. 408
Ryska, Pavel; Slezak, Ondrej; Eklund, Anders; et al.
Prevention of post-dural puncture headache: a randomized controlled trial
European Journal of Neurology, John Wiley & Sons 2020, Vol. 27 : 14-15
Salzer, Jonatan; Granåsen, Gabriel; Sundström, Peter; et al.
Prevention of post-dural puncture headache: a randomized controlled trial
European Journal of Neurology, Wiley-Blackwell 2020, Vol. 27, (5) : 871-877
Salzer, Jonatan; Granåsen, Gabriel; Sundström, Peter; et al.
Validation of the Swedish Multiple Sclerosis Register Further Improving a Resource for Pharmacoepidemiologic Evaluations
Epidemiology, Lippincott Williams & Wilkins 2019, Vol. 30, (2) : 230-233
Alping, Peter; Piehl, Fredrik; Langer-Gould, Annette; et al.
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
European Journal of Neurology, Vol. 26, (8) : 1060-1067
Boremalm, Malin; Juto, A.; Axelsson, M.; et al.
Quality of care in acute dizziness presentations
European Journal of Neurology, John Wiley & Sons 2019, Vol. 26, (S1) : 926-926
Granberg Sandlund, M.; Diamant, Anna; Granåsen, Gabriel; et al.
Effectiveness of care in acute dizziness presentations
European Archives of Oto-Rhino-Laryngology, Springer 2019, Vol. 276, (9) : 2389-2396
Granberg Sandlund, Mikael; Diamant, Anna; Granåsen, Gabriel; et al.
Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis
Multiple Sclerosis Journal, Sage Publications 2019, Vol. 25 : 20-20
Hallberg, S.; Boremalm, Malin; Evertsson, B.; et al.
Inflammatory activity and vitamin D levels in an MS population treated with rituximab
Multiple Sclerosis Journal, Experimental, Translational and Clinical, Vol. 5, (1)
Linden, Johan; Granåsen, Gabriel; Salzer, Jonatan; et al.
Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
JAMA Neurology, American Medical Association 2018, Vol. 75, (3) : 320-327
Granqvist, Mathias; Boremalm, Malin; Poorghobad, Amyar; et al.
Interaction should guide management decisions
American Journal of Neuroradiology, American Society of Neuroradiology 2018, Vol. 39, (5) : E57-E57
Johansson, Elias; Salzer, Jonatan
Dizziness and the Acute Vestibular Syndrome at the Emergency Department: A Population-Based Descriptive Study
European Neurology, S. Karger 2018, Vol. 79, (1–2) : 5-12
Ljunggren, Micaela; Persson, Julia; Salzer, Jonatan
Rituximab in multiple sclerosis: data from the swedish MS registry
Multiple Sclerosis Journal, SAGE PUBLICATIONS LTD 2016, Vol. 22 : 49-49
Alping, P.; Svenningsson, A.; Salzer, Jonatan; et al.
Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients
Annals of Neurology, Vol. 79, (6) : 950-958
Alping, Peter; Frisell, Thomas; Novakova, Lenka; et al.
CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
Neurology, Vol. 87, (11) : 1068-1069
Khalil, Michael; Salzer, Jonatan
Rituximab in paediatric onset multiple sclerosis: a case series
Journal of Neurology, Springer Berlin/Heidelberg 2016, Vol. 263, (2) : 322-326
Salzer, Jonatan; Lycke, Jan; Wickström, Ronny; et al.
How to minimize the risk for headache?: a lumbar puncture practice questionnaire study
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, Vol. 69, (11-12) : 397-402
Salzer, Jonatan; Rajda, Cecilia; Sundström, Peter; et al.
Rituximab in multiple sclerosis: a retrospective observational study on safety and efficacy
Neurology, Vol. 87, (20) : 2074-2081
Salzer, Jonatan; Svenningsson, Rasmus; Alping, Peter; et al.
Vitamin D and axonal injury in multiple sclerosis
Multiple Sclerosis Journal, Vol. 22, (8) : 1027-1031
Sandberg, L.; Bistrom, M.; Salzer, Jonatan; et al.
Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology
Multiple Sclerosis Journal, Sage Publications 2015, Vol. 21, (11) : 555-555
Alping, P.; Islam-Jakobsson, Protik; Novakova, L.; et al.
Rituximab in multiple sclerosis, a long term safety and efficacy study
Multiple Sclerosis Journal, Vol. 21 : 574-574
Islam-Jakobsson, P.; Alping, P.; Salzer, Jonatan; et al.
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES
Multiple Sclerosis Journal, Sage Publications 2015, Vol. 21, (10) : 1239-1240
Salzer, Jonatan
Are we minimizing the patients' risk for headache?: a lumbar puncture practice questionnaire study among European neurologists
Multiple Sclerosis Journal, Vol. 21 : 733-734
Salzer, Jonatan; Rajda, C.; Sundström, Peter; et al.
Rituximab in paediatric MS
Multiple Sclerosis Journal, Vol. 21 : 380-380
Salzer, Jonatan; Wickstrom, R.; Piehl, F.; et al.
Vitamin D and multiple sclerosis from epidemiology to prevention
Acta Neurologica Scandinavica, Vol. 132, (Supplement 199) : 56-61
Sundstrom, Peter; Salzer, Jonatan
Increasing prevalence of multiple sclerosis in Vasterbotten County of Sweden
Acta Neurologica Scandinavica, Vol. 132, (6) : 389-394
Svenningsson, Anders; Salzer, Jonatan; Vågberg, Mattias; et al.
The trials and tribulations of vitamin D: time for the ‘sunshine’ vitamin to come in out of the cold – or just more broken promises?
Expert review of Endocrinology & Metabolism, Informa Healthcare 2014, Vol. 9, (4) : 327-344
Leckstroem, Daniel; Salzer, Jonatan; Goldsmith, David
Vitamin D and multiple sclerosis: where do we go from here?
Expert Review of Neurotherapeutics, Informa 2014, Vol. 14, (1) : 9-18
Salzer, Jonatan; Biström, Martin; Sundström, Peter
The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age
Multiple Sclerosis Journal, Sage Publications 2014, Vol. 20, (6) : 747-750
Salzer, Jonatan; Stenlund, Hans; Sundström, Peter
MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study
Neurology, Vol. 83, (22) : 2099-2100
Svenningsson, Anders; Sundström, Peter; Salzer, Jonatan; et al.
Environmental risk factors for multiple sclerosis
Umeå University medical dissertations, 1545
Salzer, Jonatan
Maternal vitamin D status during pregnancy and bone-mineral content in offspring
The Lancet, Vol. 382, (9894) : 766-767
Salzer, Jonatan; Goldsmith, David
Smoking as a risk factor for multiple sclerosis
Multiple Sclerosis Journal, Sage Publications 2013, Vol. 19, (8) : 1022-1027
Salzer, Jonatan; Hallmans, Göran; Nyström, Maria; et al.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis
Multiple Sclerosis Journal, Sage Publications 2013, Vol. 19, (8) : 1046-1051
Salzer, Jonatan; Hallmans, Göran; Nyström, Maria; et al.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No
Multiple Sclerosis Journal, Sage Publications 2013, Vol. 19, (13) : 1692-1693
Salzer, Jonatan; Myhr, Kjell-Morten
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank sampels
Multiple Sclerosis Journal, Sage Publications 2013, Vol. 19, (12) : 1587-1591
Salzer, Jonatan; Nyström, Maria; Hallmans, Göran; et al.
Timing of cigarette smoking as a risk factor for multiple sclerosis
Therapeutic advances in neurological disorders, Sage Publications 2013, Vol. 6, (3) : 205-205
Salzer, Jonatan; Sundström, Peter
Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention
Biomarkers in Medicine, Vol. 7, (2) : 193-195
Sundström, Peter; Salzer, Jonatan
Vitamin D as a protective factor in multiple sclerosis
Neurology, Vol. 79, (21) : 2140-2145
Salzer, Jonatan; Hallmans, Göran; Nyström, Maria; et al.
Season of birth and multiple sclerosis in Sweden
Acta Neurologica Scandinavica, Vol. 122, (1) : 70-73
Salzer, Jonatan; Svenningsson, Anders; Sundström, Peter
Neurofilament light as a prognostic marker in multiple sclerosis
Multiple Sclerosis Journal, Vol. 16, (3) : 287-292
Salzer, Jonatan; Svenningsson, Anders; Sundström, Peter
Visa publikationer i DiVA